Intra-Cellular Therapies
(NASDAQ:ITCI)
$65.00
-1.53[-2.30%]
At close: May 17
$65.00
0[0.00%]
After Hours: 4:00PM EDT
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
2
Dec 23
3
1
Jan
5
Feb
10
1
Apr
2
May
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
ITCI
NVO

FAQ

Q

How do I buy Intra-Cellular Therapies (ITCI) stock?

A

You can purchase shares of Intra-Cellular Therapies (NASDAQ: ITCI) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Intra-Cellular Therapies's (ITCI) competitors?

A

Other companies in Intra-Cellular Therapies’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).

Q

What is the target price for Intra-Cellular Therapies (ITCI) stock?

A

The latest price target for Intra-Cellular Therapies (NASDAQ: ITCI) was reported by Needham on Wednesday, May 8, 2024. The analyst firm set a price target for 90.00 expecting ITCI to rise to within 12 months (a possible 38.46% upside). 37 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Intra-Cellular Therapies (ITCI)?

A

The stock price for Intra-Cellular Therapies (NASDAQ: ITCI) is $65 last updated May 17, 2024 at 4:00 PM EDT.

Q

Does Intra-Cellular Therapies (ITCI) pay a dividend?

A

There are no upcoming dividends for Intra-Cellular Therapies.

Q

When is Intra-Cellular Therapies (NASDAQ:ITCI) reporting earnings?

A

Intra-Cellular Therapies’s Q2 earnings are confirmed for Thursday, August 1, 2024.

Q

Is Intra-Cellular Therapies (ITCI) going to split?

A

There is no upcoming split for Intra-Cellular Therapies.

Q

What sector and industry does Intra-Cellular Therapies (ITCI) operate in?

A

Intra-Cellular Therapies is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

People Also Watch